More than 190 vaccines are currently in development to prevent infection by the novel severe
acute respiratory syndrome coronavirus 2. Animal studies suggest that while neutralizing …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …

Introduction The presence of a new autoantibody system, anti-carbamylated protein (anti-CarP)
antibodies, has been identified in rheumatoid arthritis (RA). The presence of anti-CarP …

Objective In rheumatoid arthritis ( RA ), anti–citrullinated protein antibodies ( ACPA s) and
rheumatoid factor ( RF ) are commonly used to aid in the diagnosis. Although these …

Background The presence of rheumatoid factor (RF), anti-carbamylated protein antibodies (anti-CarP)
and antibodies against citrullinated protein and peptides (ACPA) precedes the …

Introduction Rheumatoid arthritis–associated autoantibodies (RA-AAB) can be present in
serum years before clinical onset of rheumatoid arthritis (RA). It has been hypothesized that …

Objectives Autoantibody testing is helpful for predicting the risk of progression to clinical
arthritis in subjects at risk. Previous longitudinal studies have mainly selected autoantibody-…

Objectives Anticarbamylated protein (anti-CarP) antibodies are a novel family of autoantibodies
recently identified in patients with inflammatory arthritis. The aim of this study was to …

mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We
compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, …

Objectives Over 50% of patients with rheumatoid arthritis (RA) harbour a variety of anti-modified
protein antibodies (AMPA) against different post-translationally modified (PTM) proteins, …